Icon

XCOPRI (nda212839)- (12.5MG,25MG,50MG,100MG,150MG,200MG)

CENOBAMATE SK LIFE
12.5MG,25MG,50MG,100MG,150MG,200MG
Yes No
2039-Jun-16 2025-Mar-10
None None
None No
XCOPRI is indicated for the treatment of partial-onset seizures in adult patients.
0 0 0
Total Other Developers 5
Drugs with Suitability No
12.5MG ** ** Up - -
25MG ** ** - - -
50MG ** ** Up - -
100MG ** ** Up - -
150MG ** ** Up - -
200MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.